Latest filing published 10 Oct 2024 for TREVENA INC, €72.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Carrie L. Bourdow is a declared insider at 3 companies (chief executive); the most frequent names are Trevena Inc, Nabriva Therapeutics plc and Sesen Bio, Inc. In total, 32 filings cover trades dated from 9 November 2016 to 8 October 2024.
On the open market, the record shows 2 purchases worth €100k and 2 sales worth €2,234. Netting one side against the other leaves €98k of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 28 share grants.
Most recently, on 10 October 2024, the filings show a share grant worth €382 in Trevena Inc. The latest purchase dates back some time: it was published 1,944 days ago, on 28 June 2021. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations